What reaches the system?
The ingredient source, dose, format, and surrounding formula define the starting point.
Joyrise
Loading the current catalog.
Absorption, decoded
Follow the path from dose to measurable exposure—and learn why formulation, route, and study model change what the evidence can actually say.
The short answer
Having DHM in a capsule is not the same as knowing how much reaches circulation—or what that exposure means for a person.
The molecule-to-moment runway
Bioavailability is one piece of the chain. Each gate asks a different question, and skipping one makes the headline less useful.
The ingredient source, dose, format, and surrounding formula define the starting point.
A compound has to leave its dosage form and enter solution before absorption is even possible.
Preclinical studies suggest raw DHM has solubility and exposure challenges. Route and model matter.
Concentration over time can describe exposure. It does not, by itself, prove a consumer outcome.
Read the curve, not the hype
Researchers often look at concentration over time. The height, timing, and area of that curve can change with formulation and route.
What the literature actually gives us
The current DHM literature includes animal, cell, and pharmacokinetic research. Study model and route belong next to every takeaway.
Researchers measured DHM and metabolites and emphasized why route, sex, limited absorption, and rapid clearance matter.
Pharmaceutics · 2021 Rat + cell researchDHM, alcohol exposure, and GABA-A pathwaysA frequently cited study used injected DHM in rats and receptor activity in cells. It was not a human trial of Joyrise.
Journal of Neuroscience · 2012 Rat + cell researchAlcohol-metabolism findings are not settledSeparate research reported no in-vivo change in alcohol metabolism and called the proposed mechanism uncertain.
Physiological Research · 2021Keep the nouns straight
Joyrise has a patented formulation approach. That is meaningful product context—but it is not a guarantee, a human trial, or proof that every person will feel the same result.
Explore the evidence roomThe current Joyrise bottle
Current label facts, clear serving math, a patented formulation, and limits that stay visible.
Five straight answers
Bioavailability describes the proportion and rate at which a compound reaches systemic circulation. The exact meaning depends on the compound, route, formulation, and study design.
Preclinical literature describes solubility, absorption, and rapid-clearance challenges for DHM. That research is useful context, but it is not the same as a human outcome study of every finished product.
No. A patent describes an invention. It does not prove a guaranteed consumer outcome. Finished-product evidence, study design, and endpoints must be considered separately.
The current bottle contains 45 capsules, 15 labeled servings, and 3 capsules per labeled serving. At $29.99, that is $1.99 per labeled serving.
No. Joyrise does not lower BAC, reverse impairment, or make driving safe. Only time lowers BAC.
The better question
Start with the label, follow the pathway, inspect the evidence, then choose the ritual that fits your plan.
Shop Joyrise Joyrise does not reduce BAC or impairment and does not make drinking safer. Never drink and drive.